Functional Consequences of Adenovirus-Mediated Murine Pancreatic Gene Transfer
- 10 April 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 8 (6), 739-746
- https://doi.org/10.1089/hum.1997.8.6-739
Abstract
Pancreatic adenoviral gene transfer can be achieved with high efficiency; however, questions concerning tissue injury from this commonly used vector have not been addressed. In these experiments, the effects of adenoviral gene transfer on pancreatic exocrine function were evaluated. Direct pancreatic injection with an adenoviral vector containing the Escherichia coli β-galactosidase (β-Gal; lacZ) transgene (H5.010CBlacZ) resulted in a high level of transgene expression (64 ± 6% of pancreatic cells expressed β-Gal) at 3 days following infection. However, amylase levels in four of five different subcellular pancreatic fractions were significantly decreased at this time point. Direct pancreatic injection with either saline or psoralen/UV-inactivated adenovirus did not have this effect, whereas both transduction with an adenoviral vector containing a different transgene and transduction with a homologous transgene resulted in decreased pancreatic amylase. The decrease in subcellular amylase levels persisted at 7 days post-transduction, and then returned to baseline at 21 days post-transduction. There was associated histologic damage (increased edema, inflammation, cell destruction, and vacuolization) at 3 and 7 days post-transduction, which resolved by 21 days. In summary, adenoviral transduction of the pancreas results in increased viral transgene expression and a uniform decrease in host amylase production throughout the pancreas. The normalization of amylase levels and histology suggest that organ recovery occurs. Gene transfer technology as a novel strategy for pancreatic diseases such as diabetes, pancreatitis, and cystic fibrosis is feasible but will benefit from continued approaches to limit toxicity. The functional effect of adenoviral administration on host organ function is an important factor to consider in the use of adenoviral vectors for gene transfer. This study evaluated the effect of pancreatic adenoviral transduction on pancreatic exocrine function. Subcellular fractionated amylase levels were determined following administration of the adenoviral vector. In addition, pancreatic histology was evaluated. We demonstrated that there was significant transgene expression and a uniform decrease in subcellular amylase content. This effect is undesirable, because organ function should not be compromised during therapeutic manipulations. However, the decrease in amylase content, as well as the pancreatic histologic damage, was transient, implying rapid organ recovery.Keywords
This publication has 20 references indexed in Scilit:
- Safety of Intrapleurally Administered Recombinant Adenovirus Carrying Herpes Simplex Thymidine Kinase DNA Followed by Ganciclovir Therapy in Nonhuman PrimatesHuman Gene Therapy, 1996
- Immediate Inflammatory Responses to Adenovirus-Mediated Gene Transfer in Rat Salivary GlandsHuman Gene Therapy, 1996
- Bile-pancreatic juice replacement not cholinergic-and cholecystokinin-receptor blockade reverses acinar cell hyperstimulation after bile-pancreatic duct ligationThe American Journal of Surgery, 1996
- Safety Evaluation of Ad5CMY-p53 In VitroandIn VivoHuman Gene Therapy, 1995
- Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2aHuman Gene Therapy, 1994
- Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemiaSomatic Cell and Molecular Genetics, 1993
- Adenovirus–mediated in vivo gene transfer and expression in normal rat liverNature Genetics, 1992
- Widespread long-term gene transfer to mouse skeletal muscles and heart.JCI Insight, 1992
- In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epitheliumCell, 1992
- Alteration of membrane fusion as a cause of acute pancreatitis in the ratDigestive Diseases and Sciences, 1982